JASON THARPE: Open Payments
NPI 1659636488 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,314 in 120 payments from 20 companies in 2025. Trend: 2023 $2,139 · 2024 $2,989 · 2025 $2,314
Food & beverage: $2,314
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 11 | $469 |
| Galderma Laboratories, L.P. | 28 | $339 |
| LEO Pharma Inc. | 9 | $247 |
| Almirall LLC | 7 | $171 |
| PFIZER INC. | 14 | $156 |
| E.R. Squibb & Sons, L.L.C. | 10 | $153 |
| Incyte Corporation | 7 | $137 |
| Novartis Pharmaceuticals Corporation | 6 | $134 |
| Arcutis Biotherapeutics, Inc. | 6 | $115 |
| Regeneron Healthcare Solutions, Inc. | 3 | $73 |
Products named: DUPIXENT, NEMLUVIO, CIBINQO, Sotyktu, OPZELURA, ADBRY, ANZUPGO, Zoryve.
Industry payments across TX — which companies pay providers there.
